Latest NBY reports update at 2024-03-26: 20232022
NovaBay Pharmaceuticals logo
NovaBay Pharmaceuticals NBY
$ 0.09 1.48%

NovaBay Pharmaceuticals Financial Statements 2011-2024 | NBY

Annual Financial Statements NovaBay Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

590 K 2.48 M 474 K 35.6 M 13.2 M 32.3 M 56.7 M 36.2 M 7.18 M 31.8 M 43.5 M 38 M 36.1 M

Shares

4.22 M 1.61 M 1.25 M 40 M 21.6 M 16.9 M 15.3 M 9.41 M 2.78 M 1.99 M 1.53 M 1.18 M 1.03 M

Historical Prices

0.14 1.54 0.38 0.7 0.64 0.77 3.85 3.3 2.02 15.8 30.8 28.2 33.5

Net Income

-9.64 M -10.6 M -5.82 M -11 M -9.66 M -6.54 M -7.4 M -13.2 M -19 M -15.2 M -16 M -7.03 M -5.08 M

Revenue

14.7 M 14.4 M 10.2 M 9.93 M 6.6 M 12.5 M 18.2 M 11.9 M 4.38 M 1.05 M 3.48 M 6.95 M 11 M

Cost of Revenue

6.83 M 6.62 M 3.69 M 3.97 M 1.74 M 1.5 M 2.78 M 2.46 M - - - - -

Gross Profit

7.9 M 7.78 M 6.52 M 5.96 M 4.86 M 11 M 15.4 M 9.43 M 3.12 M 568 K 3.32 M - 11 M

Operating Income

-7.6 M -14.4 M -8.86 M -6.43 M -9.4 M -7.87 M -7.31 M -11 M -21.1 M -16.9 M -15.5 M -8.31 M -4.32 M

Interest Expense

-2.06 M -276 K -1.58 M 605 K -1.42 M 19 K 12 K -68 K 17 K 48 K 1 K -155 K -30 K

EBITDA

-7.54 M -14.3 M -8.8 M -6.38 M -9.34 M -7.6 M -7.22 M -10.9 M -20.8 M -16.6 M -15.2 M -7.97 M -3.9 M

Operating Expenses

15.5 M 22.2 M 15.4 M 12.4 M 14.3 M 18.9 M 22.8 M 20.4 M 24.1 M 17.4 M 18.8 M 15.3 M 15.3 M

General and Administrative Expenses

6.33 M 7.49 M 7.24 M 5.93 M 5.31 M 5.83 M 8.64 M 7.24 M 18.1 M 7.94 M 6.34 M 5.98 M 5.43 M

All numbers in USD currency

Quarterly Income Statement NovaBay Pharmaceuticals

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

4.69 M 3.18 M 2.04 M 2.04 M 1.6 M 1.51 M 1.43 M 47.8 M 44.9 M 42.6 M 41.8 M 41.8 M 40 M 30.4 M 28 M 27.9 M 23.1 M 18.6 M 17.1 M 17.1 M 17.1 M 17.1 M 16.4 M 15.4 M 15.3 M 15.3 M 15.3 M 15.3 M 10.9 M 7.41 M 4.09 M 3.49 M 2.96 B 2.65 B 2.18 M 2.07 M 50.8 M 50.8 M 45.3 M 44.6 M 37.5 M 37.3 M 36.8 M 36.9 M 28.9 M 28.7 M 28.6 M 28.6 M 27.9 M 23.5 M 23.6 M

Net Income

-1.76 M -2.04 M -1.74 M - -136 K -2.16 M -111 K - -2.29 M -1.86 M -1.52 M - -3.22 M -4.48 M -1.58 M - -282 K -2.5 M -4.19 M - -1.54 M -1.59 M -2.15 M - -2.45 M -1.74 M -4.01 M - -3.74 M -2.69 M -5.08 M - -5.24 M -4.89 M -4.64 M - -4.22 M -2.94 M -3.56 M - -3.85 M -4.05 M -59.9 M - 80 K -2.23 M -2.53 M - 106 K 425 K -1.99 M

Revenue

3.26 M 4.61 M 3.12 M - 3.83 M 3.66 M 3.27 M - 2.26 M 2.13 M 1.81 M - 2.17 M 3.98 M 1.89 M - 1.62 M 1.79 M 1.49 M - 3.14 M 2.79 M 2.95 M - 4.09 M 4.12 M 3.7 M - 3.44 M 2.66 M 1.72 M - 1.2 M 1.01 M 538 K - 152 K 123 K 100 K - 1.1 M 831 K 957 K - 3.64 M 871 K 1.32 M - 2.77 M 4.53 M 2.49 M

Cost of Revenue

1.43 M 2.3 M 1.19 M - 1.45 M 1.82 M 1.46 M - 712 K 614 K 455 K - 536 K 2.04 M 581 K - 401 K 403 K 341 K - 332 K 479 K 251 K - 521 K 698 K 588 K - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

1.84 M 2.31 M 1.94 M - 2.38 M 1.84 M 1.81 M - 1.55 M 1.52 M 1.35 M - 1.63 M 1.94 M 1.31 M - 1.21 M 1.39 M 1.15 M - 2.81 M 2.32 M 2.7 M - 3.57 M 3.42 M 3.11 M - 2.87 M 2.18 M 1.11 M - 931 K 755 K 390 K - 110 K 105 K 58 K - -44 K 1 K 41 K - - - - - - - -

Operating Income

-1.12 M -1.36 M -1.73 M - -457 K -2.15 M -2.38 M - -2.29 M -1.86 M -1.52 M - -2.06 M -1.07 M -1.54 M - -1.71 M -1.38 M -4.07 M - -1.81 M -2.08 M -2.37 M - -2.17 M -1.76 M -3.78 M - -2.06 M -2.24 M -4.65 M - -5.35 M -4.86 M -4.66 M - -4.11 M -3.79 M -4.08 M - -2.98 M -4.15 M -3.49 M - -106 K -2.88 M -2.48 M - -348 K 440 K -1.94 M

Interest Expense

-641 K -937 K -5 K - -171 K -3 K -4 K - - 2 K 2 K - 429 K 362 K -186 K - -719 K -387 K -60 K - 4 K 5 K 4 K - 3 K 4 K 2 K - -4 K -24 K -41 K - -31 K -22 K -11 K - -2 K 57 K -7 K - 3 K 5 K - - -17 K 27 K -5 K - 6 K -11 K -31 K

EBITDA

-1.1 M -1.34 M -1.72 M - -428 K -2.12 M -2.35 M - -2.28 M -1.85 M -1.51 M - -2.05 M -1.06 M -1.52 M - -1.7 M -1.36 M -4.05 M - -1.72 M -2 M -2.33 M - -2.15 M -1.74 M -3.76 M - -2.03 M -2.21 M -4.61 M - -5.31 M -4.78 M -4.62 M - -3.93 M -3.64 M -4.01 M - -2.74 M -3.99 M -833 K - 150 K -2.7 M -2.39 M - -27 K 656 K -1.84 M

Operating Expenses

2.95 M 3.66 M 3.67 M - 2.83 M 3.99 M 4.2 M - 3.84 M 3.38 M 2.87 M - 3.7 M 3.02 M 2.85 M - 2.93 M 2.76 M 5.22 M - 4.62 M 4.4 M 5.06 M - 5.74 M 5.18 M 6.89 M - 4.93 M 4.42 M 5.76 M - 6.28 M 5.61 M 5.05 M - 4.22 M 3.89 M 4.24 M - 4.04 M 4.98 M 4.48 M - 3.75 M 3.75 M 3.8 M - 3.12 M 4.09 M 4.44 M

General and Administrative Expenses

1.23 M 1.92 M 1.99 M - 956 K 1.91 M 2.18 M - 1.77 M 1.57 M 1.19 M - 1.88 M 1.48 M 1.28 M - 1.33 M 1.2 M 1.6 M - 1.34 M 1.36 M 1.62 M - 2.31 M 1.74 M 3.09 M - 2.27 M 1.29 M 1.68 M - 1.68 M 1.95 M 1.55 M - 1.91 M 1.65 M 1.71 M - 1.52 M 2.04 M 1.56 M - 1.23 M 1.37 M 1.54 M - 1.1 M 1.32 M 1.52 M

All numbers in USD currency